CNOT2

CNOT2 Full Name

CCR4-NOT transcription complex, subunit 2

CNOT2 Introduction

CCR4-NOT transcription complex subunit 2 (CNOT2) is a core scaffold component of the evolutionarily conserved CCR4-NOT multiprotein complex, which functions as a master regulator of gene expression. Encoded by the CNOT2 gene on chromosome 12q15, CNOT2 serves as a critical structural platform that bridges the deadenylase module (CNOT6/CNOT6L and CNOT7/CNOT8) with the NOT module (CNOT1, CNOT2, CNOT3) of the complex. The CCR4-NOT complex is involved in virtually every stage of mRNA metabolism, from transcription initiation and elongation to cytoplasmic mRNA deadenylation, translational repression, and mRNA quality control.

Figure 1. Strcuture of Protein CNOT2.

CNOT2 as a Structural and Functional Hub of the CCR4-NOT Complex
CNOT2 occupies a central position in the CCR4-NOT complex architecture, interacting directly with CNOT1 (the largest scaffolding subunit) and CNOT3 to form the NOT submodule. Through these interactions, CNOT2 stabilizes the overall complex structure and facilitates the recruitment of the catalytic deadenylase subunits. CNOT2 contains a NOT-box domain that mediates its association with CNOT1, while its C-terminal region contributes to CNOT3 binding. Functionally, CNOT2 participates in the selective degradation of specific mRNA subsets — notably, it is implicated in the miRNA-mediated silencing pathway where the CCR4-NOT complex is recruited to target mRNAs by the GW182/TNRC6 adaptor proteins, promoting deadenylation and subsequent decay. CNOT2 also influences the transcriptional elongation rate through interactions with RNA polymerase II-associated factors.

CNOT2 in Development and Disease
CNOT2 is essential for embryonic development, with homozygous knockout in mice resulting in early embryonic lethality, underscoring its indispensable role in gene expression control during organismal development. Heterozygous loss-of-function mutations in CNOT2 have been identified in patients with intellectual disability and neurodevelopmental disorders, characterized by speech delay, motor dysfunction, and behavioral abnormalities — collectively termed CNOT2-related neurodevelopmental syndrome. At the cellular level, CNOT2 deficiency leads to dysregulated mRNA stability of genes critical for neuronal differentiation and synaptic function. In cancer biology, CNOT2 has been reported to be overexpressed in certain tumor types where it may contribute to oncogenic mRNA stabilization, while in other contexts its loss (e.g., through 12q15 deletions) may promote tumorigenesis through genomic instability, reflecting a complex, tissue-dependent role.

Alternate Names for CNOT2

CNOT2; CCR4-NOT transcription complex, subunit 2; NOT2; CCR4-NOT transcription complex subunit 2; CDC36; NOT2H; CCR4-associated factor 2; negative regulator of transcription 2; HSPC131; FLJ26456;